Addiction I & II Flashcards
1
Q
Definition of substance use disorders
A
- 11 criteria including e.g.:
- substance taken in large amounts/long period
- unable to cut down/control substance use
- ==> social/interpersonal problems
- tolerance or withdrawal
- mild: 2-3 sx
- moderate: 4-5 sx
- severe: 6+ sx
2
Q
Neurobiology of substance abuse
A
- multiple brain regions involved
- motivational systems/reward:
- ventral tegmental area ==>
- nucleus accumbens
- frontal regions/prefrontal cortex
- learning, cognitive control, inhibition
- mood and stress reactivity
- all substances of abuse ==> dopamine release @ nucleus accumbens
3
Q
Medications available to treat alcohol abuse
A
- disulfiram (Antabuse)
- inhibits acetaldehyde dehydrogenase
- ==> antabuse rxn
- Naltrexone
- opiod antagonist
- (possibly) blocks euphoria from alcohol
- Acamprosate
- enhances GABA transmission
- interferes w/glutamate transmission
- possible restoration of GABA/glutamate balance
4
Q
Medications available to treat opioid abuse
A
- methadone
- long-acting opioid agonist
- doesn’t always lead to complete abstinence, but reduces harm and increases positive outcomes
- buprenorphine
- partial opioid agonist/naloxone
- can precipitate w/drawal
- naltrexone
- blocks effects of heroin
- can precipitate withdrawal
5
Q
Medications available to treat tobacco abuse
A
- NRT
- can lead to rash, tachycardia
- Buproprion
- nicotinic receptor antagonist
- dopamine reuptake inhibitor
- doubles quit rates
- Varenicline
- partial alpha4beta2 agonist
- some reports of depression/suicidal ideation
6
Q
Psychosocial tx of substance abuse
A
- Contingency management
- Motivational interviewing
- Cognitive behavioral therapy
- Twelve step facilitation
7
Q
Contraindications of Disulfram (Antabuse use)
A
- Risk for MI
- Risk for CVA
- Cognitive dysfunction (can’t remember what will happen if drinks)
- Pregnancy
8
Q
“free-will” vs. biological disease in substance abuse disorders
A
- All drugs of abuse share the final common pathway of increasing dopamine release in the nucleus accumbens; associated with the “high” (reward reinforcement)
- Over time, dopamine circuitry compensates so that individuals now have to use drugs to create physiological normal levels of dopamine
- Orbitofrontal cortex
- SUD patients have decreased response-reversal learning, mediated by the OFC; i.e. they do not learn to alter their behavior when behavior that was previously rewarded/reinforced is now punished
9
Q
Age impact on development of SUD
A
- brain circuits involved:
- dopamine-reward sytem ==> reinforcement of SUD
- prefrontal cortex ==> resists development of SUD
- circuits ==> susceptability of teenage development of SUD b/c reward system is fully developed while prefrontal cortex is not
10
Q
Factors that impact SUD
A
- Substance availability
- Pharmacological reinforcement (e.g. withdrawal ==> reinforced substance use)
- History of prior substance abuse
- Genes
- Gender (M>F by time young adulthood is reached)
- Age (Teenagers = susceptible)
- Risk-taking disposition
- Stress
- social punishment/reinforcement
11
Q
Genetic impact on SUDs
A
- ~ 50% heritability (based on twin and adoption studies)
- First degree relatives w/SUD ==> higher rates of SUD
- Rats can be bred to create lines that are highly susceptible to drug addiction
12
Q
Important screening tools for SUDs
A
- AUDIT (Alcohol Use Disorder Identification Test)
- “At Risk Drinking”
- Men: > 5 standard drinks in a day, or >14 per week
- Women: > 4 in a day or >7 per week